Loading company…
Optieum Biotechnologies develops CAR-T therapies for cancer and other diseases.
Optieum Biotechnologies develops T-cell therapies, with a focus on CAR-T treatments for cancer. It works with healthcare providers, research institutions, and biopharmaceutical companies. Founded in 2020, the company is based in Toon, Japan, and raised venture funding from Vision Incubate in April 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in